2020 Q4 Form 10-K Financial Statement
#000156459021015214 Filed on March 25, 2021
Income Statement
| Concept | 2020 Q4 | 2019 Q4 | 2019 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $3.780M | $2.420M | $5.290M |
| YoY Change | 56.2% | 236.11% | 257.43% |
| % of Gross Profit | |||
| Research & Development | $8.770M | $7.190M | $21.35M |
| YoY Change | 21.97% | 94.85% | 56.04% |
| % of Gross Profit | |||
| Depreciation & Amortization | $10.00K | $10.00K | $17.00K |
| YoY Change | 0.0% | 0.0% | 70.0% |
| % of Gross Profit | |||
| Operating Expenses | $12.55M | $9.610M | $26.64M |
| YoY Change | 30.59% | 117.91% | 75.73% |
| Operating Profit | -$9.611M | ||
| YoY Change | 118.04% | ||
| Interest Expense | |||
| YoY Change | |||
| % of Operating Profit | |||
| Other Income/Expense, Net | -$120.0K | -$9.540M | -$30.56M |
| YoY Change | -98.74% | 4670.0% | 2986.87% |
| Pretax Income | -$12.66M | -$19.15M | -$57.20M |
| YoY Change | -33.89% | 315.4% | 254.19% |
| Income Tax | -$80.00K | $130.0K | $218.0K |
| % Of Pretax Income | |||
| Net Earnings | -$12.58M | -$19.28M | -$57.42M |
| YoY Change | -34.76% | 315.76% | 254.88% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$631.5K | -$1.398M | -$4.164M |
| COMMON SHARES | |||
| Basic Shares Outstanding | |||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2020 Q4 | 2019 Q4 | 2019 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $204.6M | $93.30M | $93.30M |
| YoY Change | 119.29% | 733.04% | |
| Cash & Equivalents | $98.18M | $93.34M | $93.30M |
| Short-Term Investments | $106.4M | ||
| Other Short-Term Assets | $5.500M | $2.000M | $2.000M |
| YoY Change | 175.0% | 1900.0% | |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | |||
| Other Receivables | |||
| Total Short-Term Assets | $210.2M | $95.33M | $95.30M |
| YoY Change | 120.51% | 742.4% | 743.36% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $166.0K | $155.0K | $200.0K |
| YoY Change | 7.1% | 369.7% | |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $706.0K | $72.00K | $100.0K |
| YoY Change | 880.56% | ||
| Total Long-Term Assets | $872.0K | $227.0K | $300.0K |
| YoY Change | 284.14% | 328.3% | 200.0% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $210.2M | $95.33M | $95.30M |
| Total Long-Term Assets | $872.0K | $227.0K | $300.0K |
| Total Assets | $211.1M | $95.55M | $95.60M |
| YoY Change | 120.9% | 740.47% | 738.6% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $2.065M | $989.0K | $1.000M |
| YoY Change | 108.8% | -34.46% | -33.33% |
| Accrued Expenses | $6.048M | $4.620M | $4.600M |
| YoY Change | 30.91% | 293.86% | 283.33% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $8.113M | $5.600M | $5.600M |
| YoY Change | 44.88% | 28.65% | 27.27% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | |||
| YoY Change | |||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $8.113M | $5.600M | $5.600M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $8.113M | $5.600M | $5.600M |
| YoY Change | 44.88% | 27.27% | |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$123.1M | -$73.60M | |
| YoY Change | 67.26% | 354.97% | |
| Common Stock | $326.1M | $163.5M | |
| YoY Change | 99.38% | 137328.57% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $203.0M | $89.94M | $89.90M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $211.1M | $95.55M | $95.60M |
| YoY Change | 120.9% | 740.47% | 738.6% |
Cashflow Statement
| Concept | 2020 Q4 | 2019 Q4 | 2019 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$12.58M | -$19.28M | -$57.42M |
| YoY Change | -34.76% | 315.76% | 254.88% |
| Depreciation, Depletion And Amortization | $10.00K | $10.00K | $17.00K |
| YoY Change | 0.0% | 0.0% | 70.0% |
| Cash From Operating Activities | -$14.02M | -$11.13M | -$25.46M |
| YoY Change | 25.97% | 238.3% | 104.17% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$10.00K | -$110.0K | $139.0K |
| YoY Change | -90.91% | -447.5% | |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$29.03M | ||
| YoY Change | |||
| Cash From Investing Activities | -$29.03M | -$110.0K | -$139.0K |
| YoY Change | 26290.91% | 247.5% | |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $11.00K | ||
| YoY Change | -99.95% | ||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -320.0K | 88.37M | 107.7M |
| YoY Change | -100.36% | 881.89% | 353.1% |
| NET CHANGE | |||
| Cash From Operating Activities | -14.02M | -11.13M | -25.46M |
| Cash From Investing Activities | -29.03M | -110.0K | -139.0K |
| Cash From Financing Activities | -320.0K | 88.37M | 107.7M |
| Net Change In Cash | -43.37M | 77.13M | 82.10M |
| YoY Change | -156.23% | 1250.79% | 629.16% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$14.02M | -$11.13M | -$25.46M |
| Capital Expenditures | -$10.00K | -$110.0K | $139.0K |
| Free Cash Flow | -$14.01M | -$11.02M | -$25.60M |
| YoY Change | 27.13% | 234.95% | 105.95% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
| CY2020 | dei |
Entity File Number
EntityFileNumber
|
001-39122 | |
| CY2020 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
142 Sansome Street | |
| CY2020 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
| CY2020 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94104 | |
| CY2020 | dei |
City Area Code
CityAreaCode
|
415 | |
| CY2020 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
| CY2020 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
| CY2020 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
36-4946844 | |
| CY2020 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Second Floor | |
| CY2020 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
San Francisco | |
| CY2020 | dei |
Local Phone Number
LocalPhoneNumber
|
500-4614 | |
| CY2020 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020 | dei |
Trading Symbol
TradingSymbol
|
ETNB | |
| CY2020 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
| CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
98183000 | |
| CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
93335000 | |
| CY2020Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
25000 | |
| CY2020 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
| CY2020 | dei |
Security12b Title
Security12bTitle
|
Common stock, par value $0.001 per share | |
| CY2019Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
25000 | |
| CY2020Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
106446000 | |
| CY2020Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
5548000 | |
| CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1966000 | |
| CY2020Q4 | us-gaap |
Assets Current
AssetsCurrent
|
210202000 | |
| CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
95326000 | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
166000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
155000 | |
| CY2020Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
706000 | |
| CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
72000 | |
| CY2020Q4 | us-gaap |
Assets
Assets
|
211074000 | |
| CY2019Q4 | us-gaap |
Assets
Assets
|
95553000 | |
| CY2020Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
2065000 | |
| CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
989000 | |
| CY2020Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
6048000 | |
| CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4620000 | |
| CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
14000 | |
| CY2019Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
163526000 | |
| CY2020Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
| CY2019Q4 | us-gaap |
Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
|
0.001 | |
| CY2020Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
10000000 | |
| CY2020 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
| CY2020 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
| CY2020 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
| CY2019 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-24.49 | |
| CY2020 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-3.08 | |
| CY2019 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-57420000 | |
| CY2020 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-10000 | |
| CY2020 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-49509000 | |
| CY2019 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
159000 | |
| CY2019Q4 | us-gaap |
Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
|
10000000 | |
| CY2020Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | |
| CY2019Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | |
| CY2020Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | |
| CY2019Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | |
| CY2020 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-18000 | |
| CY2020 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
16087785 | |
| CY2019 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2344191 | |
| CY2019 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
49746000 | |
| CY2019 | etnb |
Capital Contribution Related To Extinguishment Of Preferred Stock Liability
CapitalContributionRelatedToExtinguishmentOfPreferredStockLiability
|
25595000 | |
| CY2019 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
389000 | |
| CY2020 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
271000 | |
| CY2020 | us-gaap |
Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
|
134000 | |
| CY2020 | etnb |
Issuance Of Common Stock Warrants In Connection With Debt Financing
IssuanceOfCommonStockWarrantsInConnectionWithDebtFinancing
|
634000 | |
| CY2020 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3807000 | |
| CY2019 | etnb |
Stock Issued During Period Issuance Costs
StockIssuedDuringPeriodIssuanceCosts
|
3083000 | |
| CY2020 | us-gaap |
Profit Loss
ProfitLoss
|
-49499000 | |
| CY2019 | us-gaap |
Profit Loss
ProfitLoss
|
-57420000 | |
| CY2020 | us-gaap |
Depreciation
Depreciation
|
60000 | |
| CY2019 | us-gaap |
Depreciation
Depreciation
|
17000 | |
| CY2020 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3807000 | |
| CY2019 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
389000 | |
| CY2020 | etnb |
Deferred Tax Assets
DeferredTaxAssets
|
69000 | |
| CY2019 | etnb |
Deferred Tax Assets
DeferredTaxAssets
|
-20000 | |
| CY2019 | etnb |
Revaluation Of Convertible Preferred Stock Liability
RevaluationOfConvertiblePreferredStockLiability
|
30597000 | |
| CY2020 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-268000 | |
| CY2020 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
230000 | |
| CY2020 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
3600000 | |
| CY2019 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1918000 | |
| CY2019 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
72000 | |
| CY2020 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1131000 | |
| CY2019 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-520000 | |
| CY2020 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1428000 | |
| CY2019 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
3447000 | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-46244000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-25460000 | |
| CY2020 | us-gaap |
Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
|
118895000 | |
| CY2020 | us-gaap |
Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
|
12189000 | |
| CY2020 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Significant estimates and assumptions made in the accompanying consolidated financial statements include but are not limited to the fair value of stock options and certain accrued expenses. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</p> | |
| CY2020 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
126000 | |
| CY2019 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
139000 | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-106832000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-139000 | |
| CY2020 | etnb |
Proceeds From Issuance Public Offering
ProceedsFromIssuancePublicOffering
|
157680000 | |
| CY2020 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Concentrations of Credit Risk</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;color:#231F20;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial<font style="letter-spacing:0.05pt;"> </font>instruments<font style="letter-spacing:0.1pt;"> </font>that<font style="letter-spacing:0.05pt;"> </font>potentially<font style="letter-spacing:0.1pt;"> </font>subject<font style="letter-spacing:0.05pt;"> </font>the Company to a concentration<font style="letter-spacing:0.1pt;"> </font>of credit<font style="letter-spacing:0.05pt;"> </font>risk<font style="letter-spacing:0.05pt;"> </font>consist primarily<font style="letter-spacing:0.1pt;"> </font>of cash and cash equivalents.<font style="letter-spacing:0.1pt;"> </font>Bank<font style="letter-spacing:-0.05pt;"> </font>deposits<font style="letter-spacing:0.05pt;"> </font>are held by accredited<font style="letter-spacing:0.1pt;"> </font>financial<font style="letter-spacing:0.1pt;"> </font>institutions<font style="letter-spacing:0.1pt;"> </font>and these deposits<font style="letter-spacing:0.05pt;"> </font>may at times<font style="letter-spacing:0.05pt;"> </font>be in excess<font style="letter-spacing:0.05pt;"> </font>of insured<font style="letter-spacing:0.05pt;"> </font>limits. The Company limits<font style="letter-spacing:0.1pt;"> </font>its<font style="letter-spacing:0.05pt;"> </font>credit<font style="letter-spacing:0.05pt;"> </font>risk<font style="letter-spacing:0.05pt;"> </font>associated<font style="letter-spacing:0.1pt;"> </font>with cash and cash equivalents<font style="letter-spacing:0.1pt;"> </font>by placing<font style="letter-spacing:0.05pt;"> </font>them<font style="letter-spacing:0.05pt;"> </font>with financial<font style="letter-spacing:0.1pt;"> </font>institutions<font style="letter-spacing:0.1pt;"> </font>that<font style="letter-spacing:0.05pt;"> </font>it believes<font style="letter-spacing:0.05pt;"> </font>are of high quality.<font style="letter-spacing:0.05pt;"> </font>The Company has not experienced<font style="letter-spacing:0.05pt;"> </font>any losses<font style="letter-spacing:0.05pt;"> </font>on its<font style="letter-spacing:0.05pt;"> </font>deposits<font style="letter-spacing:0.05pt;"> </font>of cash or cash equivalents. </p> | |
| CY2019 | us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
87691000 | |
| CY2019 | us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
20000000 | |
| CY2020 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
271000 | |
| CY2019 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
11000 | |
| CY2020 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
161000 | |
| CY2020 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
157924000 | |
| CY2019 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
107702000 | |
| CY2020 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
4848000 | |
| CY2019 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
82103000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
93360000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11257000 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
98208000 | |
| CY2020Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
25000 | |
| CY2019Q4 | us-gaap |
Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
|
25000 | |
| CY2020 | etnb |
Issuance Of Common Stock Warrant In Connection With Term Loan Facility
IssuanceOfCommonStockWarrantInConnectionWithTermLoanFacility
|
634000 | |
| CY2019 | etnb |
Property And Equipment Purchases Included In Accounts Payable
PropertyAndEquipmentPurchasesIncludedInAccountsPayable
|
55000 | |
| CY2020 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
142000 | |
| CY2019 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
106000 | |
| CY2019 | etnb |
Conversion Of Convertible Preferred Stock Into Common Stock At Initial Public Offering
ConversionOfConvertiblePreferredStockIntoCommonStockAtInitialPublicOffering
|
49746000 | |
| CY2020 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Reclassification</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:5.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior year footnote amounts have been updated for consistency with the current year presentation. Such reclassification has no effect on the consolidated financial statements.</p> | |
| CY2019Q4 | etnb |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
2326000 | |
| CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2552000 | |
| CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1396000 | |
| CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
453000 | |
| CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
573000 | |
| CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
159000 | |
| CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
325000 | |
| CY2020 | dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2019-06-30 | |
| CY2020 | etnb |
Reorganization Exchange Of Equity Percentage Of Common Stock Issued Upon Exchange
ReorganizationExchangeOfEquityPercentageOfCommonStockIssuedUponExchange
|
1.00 | |
| CY2020 | etnb |
Reorganization Exchange Of Equity Percentage Of Ordinary Shares Exchanged
ReorganizationExchangeOfEquityPercentageOfOrdinarySharesExchanged
|
1.00 | |
| CY2019Q4 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.160849 | |
| CY2020Q4 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
204600000 | |
| CY2020 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | |
| CY2020 | us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
0 | |
| CY2020 | etnb |
Capital Contributions Related To Extinguishment Of Preferred Stock Liability
CapitalContributionsRelatedToExtinguishmentOfPreferredStockLiability
|
25600000 | |
| CY2020Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
|
0 | |
| CY2020Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
249000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
178000 | |
| CY2020Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
83000 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
23000 | |
| CY2020Q4 | etnb |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
2884000 | |
| CY2019Q4 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P24M | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
232000 | |
| CY2020 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-11000 | |
| CY2019 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
-167000 | |
| CY2020 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
1000 | |
| CY2018Q2 | us-gaap |
Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
|
The lease term expires in April 2021 and the Company has an option to renew for an additional 12 months. | |
| CY2018Q2 | etnb |
Operating Lease Monthly Rental Payments
OperatingLeaseMonthlyRentalPayments
|
4000 | |
| CY2018Q2 | us-gaap |
Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
|
P12M | |
| CY2019Q4 | us-gaap |
Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
|
The lease term is for 24 months, expiring in January 2022 | |
| CY2020 | etnb |
Operating Lease Monthly Rental Payments
OperatingLeaseMonthlyRentalPayments
|
17500 | |
| CY2020Q4 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
8000 | |
| CY2020Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
240000 | |
| CY2020 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
273000 | |
| CY2019Q4 | etnb |
Capital Contribution Related To Extinguishment Of Preferred Stock Liability
CapitalContributionRelatedToExtinguishmentOfPreferredStockLiability
|
25600000 | |
| CY2020 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3807000 | |
| CY2019 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
389000 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term Simplified Method
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod
|
P10Y | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.864 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.976 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.002 | |
| CY2020 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.015 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term Simplified Method
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTermSimplifiedMethod
|
P10Y | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.618 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.876 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.016 | |
| CY2019 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.026 | |
| CY2020 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | |
| CY2019 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.21 | |
| CY2019 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
-1000 | |
| CY2019 | us-gaap |
Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
|
-30000 | |
| CY2020 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-10000 | |
| CY2019 | us-gaap |
Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
|
-198000 | |
| CY2020 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
69000 | |
| CY2019 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-20000 | |
| CY2020 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
69000 | |
| CY2019 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-20000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
5392000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
|
3419000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
635000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
|
349000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
658000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Other
DeferredTaxAssetsOther
|
10000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
22005000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
10022000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
21936000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
10022000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
69000 | |
| CY2020 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
11900000 | |
| CY2019 | us-gaap |
Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
|
6500000 | |
| CY2020 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
Federal net operating losses generated after 2017 can be carried forward indefinitely but utilization will be limited to 80% of taxable income in the period that net operating losses are being utilized. | |
| CY2020Q4 | etnb |
Taxable Income Utilization Percentage
TaxableIncomeUtilizationPercentage
|
0.80 | |
| CY2020Q4 | etnb |
Deferred Tax Assets Tax Credit Carryforwards Research Federal
DeferredTaxAssetsTaxCreditCarryforwardsResearchFederal
|
600000 | |
| CY2020Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
700000 | |
| CY2019Q4 | us-gaap |
Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
|
200000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
8285000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
13095000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
|
815000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
|
93000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-11914000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-6520000 | |
| CY2020 | etnb |
Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization
IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization
|
647000 | |
| CY2019 | etnb |
Income Tax Reconciliation Change In Effective Tax Rate Due To Reorganization
IncomeTaxReconciliationChangeInEffectiveTaxRateDueToReorganization
|
-734000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
|
1671000 | |
| CY2019 | etnb |
Income Tax Reconciliation Revaluation Of Convertible Preferred Share Liability
IncomeTaxReconciliationRevaluationOfConvertiblePreferredShareLiability
|
-6039000 | |
| CY2020 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
555000 | |
| CY2019 | us-gaap |
Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
|
-113000 | |
| CY2020 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
300000 | |
| CY2019 | us-gaap |
Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
|
39000 | |
| CY2020Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
| CY2020 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3332386 | |
| CY2019 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2844193 |
